Cargando…
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
BACKGROUND: Primaquine (PQ) is recommended as an addition to standard malaria treatments in pre-elimination settings due to its pronounced activity against mature Plasmodium falciparum gametocytes, the parasite stage responsible for onward transmission to mosquitoes. However, PQ may trigger haemolys...
Autores principales: | Awandu, Shehu S., Raman, Jaishree, Makhanthisa, Takalani I., Kruger, Philip, Frean, John, Bousema, Teun, Niemand, Jandeli, Birkholtz, Lyn-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859786/ https://www.ncbi.nlm.nih.gov/pubmed/29558929 http://dx.doi.org/10.1186/s12936-018-2271-z |
Ejemplares similares
-
Ultralow-density Plasmodium falciparum Infections in African Settings
por: Awandu, Shehu S, et al.
Publicado: (2019) -
Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012) -
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
por: Mwaiswelo, Richard O., et al.
Publicado: (2022) -
Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
por: Raman, Jaishree, et al.
Publicado: (2019) -
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa
por: van Beek, Stijn W., et al.
Publicado: (2021)